BlackRock Investment Management, LLC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 77 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q4 2016$223,000
-53.9%
292,650
+4.0%
0.00%
-100.0%
Q3 2016$484,000
-4.7%
281,494
-0.2%
0.00%0.0%
Q2 2016$508,000
+1932.0%
282,158
+2517.2%
0.00%
Q1 2016$25,0000.0%10,7810.0%0.00%
Q4 2015$25,0000.0%10,781
-1.4%
0.00%
Q3 2015$25,0000.0%10,929
+26.6%
0.00%
Q2 2015$25,000
+19.0%
8,632
-9.6%
0.00%
Q1 2015$21,000
+50.0%
9,5450.0%0.00%
Q4 2014$14,0000.0%9,545
+23.6%
0.00%
Q3 2014$14,000
+7.7%
7,723
+2.6%
0.00%
Q2 2014$13,0007,5250.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Third Security, LLC 13,238,268$6,726,0000.58%
MSD Partners, L.P. 4,118,402$2,092,0000.11%
683 Capital Management, LLC 1,500,000$762,0000.06%
Vivaldi Capital Management LP 101,145$51,0000.04%
Alyeska Investment Group, L.P. 5,000,000$2,540,0000.02%
BARD ASSOCIATES INC 56,499$29,0000.01%
FRANKLIN STREET ADVISORS INC /NC 126,000$64,0000.01%
Virtu Financial LLC 299,577$152,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 46,981$24,0000.01%
Stanley-Laman Group, Ltd. 60,323$31,0000.01%
View complete list of SYNTHETIC BIOLOGICS INC shareholders